Recent progress of prostate cancer biomarkers
Prostate cancer is a common malignant tumor in men, which seriously endangers men's health. At present, in the treatment of prostate cancer in different stages, the survival of patients shows differences, and the survival rate of early prostate cancer is high. The prognosis is good, the surv...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Editorial Board of Journal of Hainan Medical University
2021-07-01
|
| Series: | Journal of Hainan Medical University |
| Subjects: | |
| Online Access: | http://www.hnykdxxb.com/PDF/202114/13.pdf |
| id |
doaj-f4a9df8a72514499a632728e862d338a |
|---|---|
| record_format |
Article |
| spelling |
doaj-f4a9df8a72514499a632728e862d338a2021-08-26T02:15:08ZengEditorial Board of Journal of Hainan Medical UniversityJournal of Hainan Medical University1007-12372021-07-0127137680Recent progress of prostate cancer biomarkersGuo-Chen Zhao0Departmetn of urology, the first hospital of Sahn xi medical university, Taiyuan 030001, ChinaProstate cancer is a common malignant tumor in men, which seriously endangers men's health. At present, in the treatment of prostate cancer in different stages, the survival of patients shows differences, and the survival rate of early prostate cancer is high. The prognosis is good, the survival rate of advanced prostate cancer is low, and the prognosis is poor. Digital rectal examination combined with serum PSA detection is currently recognized as the best method for early prostate cancer screening. However, the specificity of PSA is poor, and a large number of prostate cancer patients are overdiagnosed and overtreated. At the same time, the treatment of advanced prostate cancer also needs more reliable biomarkers to judge the treatment effect and assist clinical decision-making.http://www.hnykdxxb.com/PDF/202114/13.pdfprostate cancerbiomarkersdiagnosisprognosis |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Guo-Chen Zhao |
| spellingShingle |
Guo-Chen Zhao Recent progress of prostate cancer biomarkers Journal of Hainan Medical University prostate cancer biomarkers diagnosis prognosis |
| author_facet |
Guo-Chen Zhao |
| author_sort |
Guo-Chen Zhao |
| title |
Recent progress of prostate cancer biomarkers |
| title_short |
Recent progress of prostate cancer biomarkers |
| title_full |
Recent progress of prostate cancer biomarkers |
| title_fullStr |
Recent progress of prostate cancer biomarkers |
| title_full_unstemmed |
Recent progress of prostate cancer biomarkers |
| title_sort |
recent progress of prostate cancer biomarkers |
| publisher |
Editorial Board of Journal of Hainan Medical University |
| series |
Journal of Hainan Medical University |
| issn |
1007-1237 |
| publishDate |
2021-07-01 |
| description |
Prostate cancer is a common malignant tumor in men, which seriously endangers men's health.
At present, in the treatment of prostate cancer in different stages, the survival of patients
shows differences, and the survival rate of early prostate cancer is high. The prognosis is good,
the survival rate of advanced prostate cancer is low, and the prognosis is poor. Digital rectal
examination combined with serum PSA detection is currently recognized as the best method
for early prostate cancer screening. However, the specificity of PSA is poor, and a large number
of prostate cancer patients are overdiagnosed and overtreated. At the same time, the treatment
of advanced prostate cancer also needs more reliable biomarkers to judge the treatment effect
and assist clinical decision-making. |
| topic |
prostate cancer biomarkers diagnosis prognosis |
| url |
http://www.hnykdxxb.com/PDF/202114/13.pdf |
| work_keys_str_mv |
AT guochenzhao recentprogressofprostatecancerbiomarkers |
| _version_ |
1721196373788852224 |